Search results for abbott
Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2007.
Worldwide sales in the fourth quarter increased 16 read more »
Discuss Add this link to... Bury
Worldwide sales in the fourth quarter increased 16 read more »
Discuss Add this link to... Bury
Abbott received U.S. Food and Drug Administration (FDA) approval for SIMCOR(R), the first fixed-dose combination of two widely prescribed cholesterol therapies, Niaspan(R) (Abbott's proprietary niac
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Posted by
worldpharmanews
194 days ago
(http://www.worldpharmanews.com)
Category: Research & Development |
Discuss Add this link to... Bury
Data published in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis,
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Clinical laboratory professionals worldwide are coming together in support of an initiative to raise international awareness of the role played by clinical laboratory professionals in health care and
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Abbott (NYSE: ABT) announced financial results for the first quarter ended March 31, 2008. Diluted earnings per share, excluding specified items, were $0.63, reflecting 14.5 percent growth, at the up
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Abbott and Takeda Pharmaceutical Company Limited have concluded their TAP Pharmaceutical Products Inc. (TAP) joint venture. The closing of the agreement to evenly divide the value of the more than 30
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R
New Phase III data showed that in patients with multiple lipid problems, Abbott's investigational TriLipix(TM) (ABT-335) combined with AstraZeneca's CRESTOR(R) (rosuvastatin calcium) led to greater
read more » Discuss Add this link to... Bury
A house is the one place where a family should feel safe and secure, yet it is here that teens are prone to get prescription drugs to misuse and abuse. To help prevent teen prescription drug misuse a
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Based on the company's strong performance year-to-date, and the outlook for the remainder of the year, Abbott is raising both its sales growth and earnings-per-share forecasts for the full-year 2008
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
